Two groups of rats were anaesthetized at weekly intervals for 6 weeks with either ketamine/medetomidine alone (60 mg/O.4 mg/kg i.p.) or ketamine/medetomidine (45 mg/0.3 mg/kg i.p.l one hour following buprenorphine (0.05 mg/kg s.c.). Animals that received buprenorphine had longer periods of surgical anaesthesia IP = 0.041 and a greater depression of both mean pedal withdrawal score (P < 0.01) and mean respiratory rate (P = 0.0141. Mean total duration of anaesthesia was also greater in the buprenorphine group on day 1. Sleep times reduced with successive doses of anaesthetic in the buprenorphine group (P=0.024). Two animals in the buprenorphine group died. Repeated anaesthesia with ketamine/medetomidine alone was not associated with anaesthetic mortality. These results indicate that although buprenorphine has a clear anaesthetic-sparing effect, its use with ketamine/medetomidine may be associated with an increased risk of anaesthetic-related mortality.
Preoperative administration of opioids may reduce postoperative analgesic requirements, while simultaneously reducing the anaesthetic dose required to attain surgical anaesthesia ILascelles et 01. 1995) . Both of these effects are generally considered desirable but the potentiation of injectable anaesthetic combinations may present practical prob-lems· in small rodents. When injectable anaesthetics are administered by the intravenous route, the dose required can be adjusted easily, depending upon the animal's response. However, in small rodents, injectable anaesthetics are usually administered as a single intraperitoneal, subcutaneous or intramuscular injection, with no opportunity for adjusting the dose during induction Correspondence to: Prof. P. A. Flecknell (Flecknell 1996) . If pre-anaesthetic administration of opioids potentiated the effects of anaesthetic agents, this could lead to relative overdosage and possible increased mortality. Other concerns might be that pre-anaesthetic administration of an opioid could cause additional respiratory depression, or could result in prolonged recovery times (Hall & Clark 1991) .
A previous study investigated the effects of buprenorphine, an opioid analgesic, and two anaesthetic regimens commonly used in laboratory rodents: pentobarbitone or the combination of ketamine with medetomidine (Roughan et 01. 1999) . Although the interactions with pentobarbitone were successfully demonstrated, 9 out of 12 animals given ketamine/medetomidine died. As a result of the study design fa randomized Accepted 1 October 1999 block design requiring that animals underwent repeated anaestheticsL it was not possible to determine whether these effects were due to the inclusion of buprenorphine in the regimen, or were due to the effects of· repeated anaesthesia. The present study was carried out to evaluate the influence of buprenorphine on ketamine/medetomidine anaesthesia in rats, and to assess the risk associated with using this anaesthetic regimen to repeatedly anaesthetize rats. The animals were divided into two groups (n = 11), to receive either ketamine/ medetomidine (60 mg/O.4 mg/kg i.p.) or ketamine/medetomidine (45 mg/0.3 mg/kg i.p.) following buprenorphine 10.05mg/kg s.c.). Animals were anaesthetized at weekly intervals for 6 weeks. Drugs were diluted with sterile water for injection, to provide a suitable volume for dosing (0.2-O.4mlj animal). Buprenorphine (0.05 mg/kg s.c.) ITemgesic} Reckitt and Coleman, Hull, England) was administered one hour prior to anaesthesia when indicated by the study design. Animals that received ketamine/ medetomidine alone were given an injection of 0.9% saline solution (0.2 ml/lOO g s.c.), similarly, one hour prior to the induction of anaesthesia. After the onset of anaesthesia (judged by loss of the righting reflex), the rats Laboratory Animals (2000) 34
Materials and methods

Animals
Hedenqvist. Roughan & Flecknell were placed on bedding ('VetBed', Kennel Needs and Feeds, Morpeth, EnglandL on a heating pad (Harvard Apparatus, Edenbridge, England) and ophthalmic ointment (Chloramphenicol BP, Martindale Pharmaceuticals Ltd, Romford, England) applied to the eyes to prevent corneal desiccation or abrasions. Additional 'VetBed' bedding was placed over the rats to further prevent heat loss and the heating pad adjusted so that rectal temperatures were maintained within the range 37.5 to 39°C throughout the anaesthesia.
Pedal withdrawal response, righting reflex, and respiratory rate were assessed every 15 min until the righting reflex returned. Pedal withdrawal responses were assessed by pinching the hind-foot metacarpal region, and were scored from 0 (no response) to 3 (strong withdrawal). The righting reflex was considered absent when the rat made no attempt to right itself when placed in dorsal recumbency. All assessments were carried out by an observer who was unaware of the treatment each rat had received. After the animals had regained their ability to perform three consecutive righting reflexes, they were placed in an incubator maintained at 28°C until normal ambulatory behaviour resumed. They were then returned to their cages in the animal room. The duration of the surgical anaesthesia was calculated as the period during which the pedal withdrawal response was absent. Total sleep time was defined as the period of loss of the righting reflex. Latency to first movement was the interval between the loss of righting reflex and the first spontaneous limb or body movement made by the rat.
Data analysis
For each respective group, means were calculated for pedal withdrawal score, respiratory rate, duration of surgical anaesthesia and total sleep time for each anaesthesia day. Repeated measures analysis of variance was used to compare these data between successive anaesthesia days. On each day, one or more animals failed to develop surgical anaesthesia and consequently, insufficient data were available for a repeated measures ANOVA incorporating all the anaesthesia days, and only days 1-4 were used in these analyses. The data were then further reduced by calculating the means for each type of assessment (pedal withdrawal score, total sleep time etc.) over all the anaesthesia days, and these were compared between groups by one-way analysis of variance. All analyses were performed using SPSS statistical software (SPSSInc., Chicago, USA). 
Results
Results are expressed as means± ISO throughout. Animals that received buprenorphine had longer periods of surgical anaesthesia (146.3±20min d. 103.5± 16.5min, P < 0.001) (Fig 1) and a greater depression of both mean pedal withdrawal score 11.3±0.01 d. 1.6±0.2, P < 0.001l and mean respiratory rate (36± 17bpm d. 64± 11bpm, P < 0.001) ( Fig  2) . Mean total sleep time was also greater in the buprenorphine group (187± 22 min d. lS7±34min, P=0.03S) (Fig 1) , as was the latency of first movement (173± 21 min d. 138± 30 min, P=0.009) (Fig 1) . Overall, with both groups included in the analysis there were no significant effects of the repeated anaesthesia on any of the variables measured. When the two groups were analysed separately, the buprenorphine group showed a tendency towards a reduction in sleep times and decreased duration of surgical anaesthesia. Total sleep time was significantly reduced between days 1 and 4 (217± 44 min d. 168±38 min, P=0.03). Surgical anaesthesia showed a significant reduction overall (P=O.002)1 with a reduction from day 1 to day 4 from 178± 11.3min to llS±36 min). Animals that did not receive buprenorphine showed an increase in sleep times from day 1 to day 4 of 123±39min to 19S±31 min (P = 0.017). Duration of surgical anaesthesia did not change significantly with successive anaesthesia days (P> 0.05). Two animals died in the buprenorphine group. With these, a progressive reduction in respiratory rates occurred prior to death. Repeated anaesthesia with ketaminej medetomidine alone was not associated with anaesthetic mortality. and strain of rat used in this study. The present study confirmed that preoperative administration of the partial 11 opioid agonist buprenorphine had an additive effect on ketaminejmedetomidine and prolonged both the duration and depth of anaesthesia, This is to be expected, since opioids have been shown to reduce the concentration of volatile anaesthetic necessary to produce surgical anaesthesia (Kay 1980 / Hecker et a1. 1983 / Stanley et a1. 1983 / Kissin et a1. 1984 ) and the dose of injectable anaesthetics required in animals and man (Michalot et a1. 1980 / DeWildt et a1. 1983 , Hilton &. Major 1986 / F1ecknell et a1. 1990 ).
Administration of buprenorphine had a small but significant effect on respiratory rates which was not judged to be of clinical significance in most animals, however two rats died following respiratory arrest. These showed a progressive reduction in their respiratory rate prior to death. Monitoring of respiratory function using pulse oximetry might have alerted the observer to impending problems, but attempts to use this technique were not successful, presumably due to the marked peripheral vasoconstriction produced by medetomidine. Other factors could have caused the death of these animals, for example cardiac arrest, or hypoxia secondary to pulmonary oedema or pulmonary vasoconstriction. More detailed investigations, with extensive monitoring of the cardiovascular and respiratory system are required to establish which factor, or factors were the primary cause of death. No attempt was made to resuscitate the two animals that died, nor was oxygen supplementation provided to any of the rats. It is important to note that administration of oxygen to counteract hypoxaemia is a valuable regimen, and the authors recommend its use. However, since the present study was designed to model the most common method of using injectable anaesthetic regimens in laboratory animal units, rather than modelling best practice, oxygen was not administered. It is possible that using a lower dose of ketaminejmedetomidine might have reduced the degree of respiratory depression, but in dose titration studies carried out earlier (Roughan et a1. 1999)/ the combination of Laboratory Animals (2000) 34 Hedenqvist. Roughan & Flecknell 45 mgjkg ketamine and 0.3 mgjkg medetomidine following 0.05 mgjkg buprenorphine failed to consistently produce surgical anaesthesia. It would seem, then, that a relatively narrow margin of safety exists when this combination of drugs is used in the rat. In contrast, in the dog and pig, ketaminej medetomidinejbutorphanol is reported to provide safe and effective anaesthesia (Sakaguchi et a1. 1996 , Tomizawa et a1. 1997 , Anon 1999 / and the combination is frequently used with dogs and cats in small animal practice in the UK and elsewhere. In the dog, buprenorphine in combination with medetomidine and midazo1am has caused slightly greater respiratory depression than when used in combination with butorphanol (Pypendop et a1. 1996) . Butorphanol has a much shorter duration of action than buprenorphine (Pircio et a1. 1976 / Cowan et a1. 1977 / and for this reason, in the authors' experience, is less widely used for postoperative analgesia in rodents, and so is less likely to be administered prior to anaesthesia in these species. In rabbits, the combination of ketaminejxylazinejbutorphanol produced anaesthesia with no mortality (Marini et a1. 1992). It is worth noting, however, that in rabbits both ketaminejxylazine and ketaminejxylazinejbutorphanol produce profound hypoxia (p02 < 50 mmHg) (Marini et 01. 1992). The results of our study indicate that buprenorphine in combination with ketamine and medetomidine in the rat can result in marked respiratory depression, and we suggest that it should not be used unless respiratory support can be provided.
The effects of repeated anaesthesia were complex. In animals given buprenorphine, a tendency towards lighter planes of anaesthesia occurred with successive anaesthetics. This contrasted with increased sleep times in the animals that received ketamine; medetomidine alone. The reduction of anaesthetic effects in animals given buprenorphine may have been due to liver enzyme induction, increased clearance rates resulting in reduced plasma concentrations of anaesthetic drugs, or to alterations in receptor or other cellular responses within the central nervous system. The increased sleep times in animals receiving ketaminej medetomidine is surprising, since repeated ketamine anaesthesia has been reported to result in progressively decreased anaesthetic effects in rats (Livingston & Waterman 1978) .
Repeated anaesthesia with ketamine/ medetomidine alone was not associated with any anaesthetic-related mortality in this study, and we conclude that the high mortality observed in previous investigations (Roughan et a1. 1999 ) was due to the use of buprenorphine in the anaesthetic regimen.
